8 Insights About the Future of Healthcare

As we step into 2024, the healthcare industry is poised for significant transformations that will shape the way we approach medical care, from AI-driven innovations to shifts in healthcare delivery models.

Here are 8 predictions about the future of the industry:

1. AI Revolutionizing Medical Education and Patient Care

Artificial intelligence and machine learning are set to revolutionize medical education and enhance the doctor-patient relationship. The emergence of the Alice L. Walton School of Medicine in 2025, with a focus on integrating arts, humanities, and cutting-edge technology, signals a commitment to training future doctors equipped with tools that augment patient care. Natural language processing for real-time dictation and reporting is one such tool, enabling doctors to spend more time addressing patients' comprehensive needs, including physical, mental, emotional, and social aspects.

2. Generative AI in Healthcare?

The year 2024 is expected to witness the transition of Generative AI in healthcare from pilot use cases to full production. However, concerns about bias and misuse in clinical delivery may prompt a reevaluation of the appropriate pace of integrating Generative AI. The Responsible AI movement is gaining momentum, with a focus on ensuring ethical and responsible use of AI in healthcare. While the hype around AI transforming medicine accelerates, clinicians remain cautious, emphasizing the need for peer-reviewed studies and FDA regulation.

3. Value-Based Mergers & Acquisitions (M&A)

In 2024, the healthcare services M&A environment is expected to be more active, with a focus on value-based M&A. Companies with business models easily integrated into acquirers' operations will be highly sought after. The emphasis on creating value and de-risking post-merger integration will drive strategic acquisitions in the healthcare sector.

The momentum towards building consumer-centric healthcare solutions is accelerating, with companies aiming to empower consumers to take control of their health. Success in this space hinges on offering comprehensive solutions, fostering genuine patient partnerships, and supporting payers with reimbursement strategies. Convenience, accessibility, and partnership are becoming expected standards in the evolving healthcare ecosystem.

4. Health Care Costs and Medicaid in Politics?

Healthcare costs as a percentage of GDP are expected to decrease in the short term, driven by improvements in care and available treatments. However, underlying growth, exacerbated by personnel shortages and labor costs, poses long-term challenges. Medicaid becomes a focal point in American politics, with a significant portion of the population relying on it for healthcare. The CMS Drug Price negotiations that made the news in 2023 is a great example of how political decisions around Medicaid could have far-reaching implications in the upcoming presidential election.

5. Regulatory Activity and AI in Healthcare

Regulatory activity is anticipated to drive investment in data privacy, AI validation, and infrastructure monitoring. The emergence of compliance-focused platforms for monitoring privacy, data, and model assets reflects the increasing importance of cybersecurity in healthcare. Organizations like the Coalition for Health AI are collaborating to develop standards and infrastructure for healthcare AI safety and ethics.?

6. Value-Based Care in Specialties

The evolution of value-based care has shifted healthcare to be more patient-centric. In 2024, a new wave of value-based care businesses is expected to emerge, particularly in specialties like Cardiology, Neurology, Nephrology, and Oncology. Evolving payment models and the approval of high-cost therapeutics and diagnostics will drive innovation. The focus on early diagnosis and advancements in therapeutics is set to transform patient care in these specialties.

7. Pressure on Medicare Advantage and Next-Gen Infrastructure

While Medicare Advantage participants have moved on to emphasis electronic prior authorizations, pressure is expected to intensify on the need for infrastructural solutions. Regulatory changes around risk adjustment data validation, the Health Equity Index, and risk sharing among specialties will drive technology disruption. AI and software are expected to play a crucial role in assessing risk, ensuring equity, and optimizing treatment outcomes.?

8. Impact of the Inflation Reduction Act and AI in Drug Discovery

The Inflation Reduction Act is expected to create challenges for patients, impacting decisions on potentially life-saving research for rare diseases. Biopharma companies may prioritize larger indications over rare-to-common strategies due to disincentives related to patent life and CMS price negotiation. AI-driven drug discovery and development will take center stage in 2024, with big pharma embracing AI-first strategies through increased business development efforts.

The future of healthcare is dynamic and multifaceted, with technological advancements, policy changes, and societal shifts playing pivotal roles. As we navigate the complexities of the healthcare landscape in 2024, it is crucial to embrace innovation responsibly, prioritize the needs of clinicians and patients, and address challenges with collaborative and forward-thinking solutions. The healthcare industry stands at the intersection of transformation, and the decisions made today will shape the healthcare landscape for years to come.

Subscribe to the NantHealth Blog to stay updated as new thought leadership content is available. Let's stay connected!